first trust dsip portfolio (@ftportfolios) / Posts / X first trust dsip portfolio Discovery

Sublingual and transdermal formulations have shown negligible absorption in bioavailability studies

In the CY 2026 OPPS/ASC proposed rule, we stated that we believed that the administrative burden for the proposal was reduced by utilizing data that hospitals would disclose under existing and proposed hospital price transparency requirements relative to if hospitals did not already have this data compiled

12 weeks (2 vials): 6 mL 1 10 mL bottle 24 weeks (5 vials): 15 mL 2 10 mL bottles Alcohol Swabs: One for the vial stopper + one for each injection site

Both are MHRA-approved, supported by large Phase 3 clinical trials, and available on prescription in the UK